Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct 8;122(3):297-304.
doi: 10.1016/j.jconrel.2007.06.014. Epub 2007 Jun 22.

PEG-b-PPA/DNA micelles improve transgene expression in rat liver through intrabiliary infusion

Xuan Jiang  1 , Hui Dai, Chyan-Ying Ke, Xiao Mo, Michael S Torbenson, Zhiping Li, Hai-Quan Mao
Affiliations

PEG-b-PPA/DNA micelles improve transgene expression in rat liver through intrabiliary infusion

Xuan Jiang et al. J Control Release. .

Abstract

We have developed a new block copolymer gene carrier that comprises of a polyethylene glycol segment and a degradable cationic polyphosphoramidate (PPA) segment. This PEG-b-PPA copolymer carrier formed micelles upon condensation with plasmid DNA in aqueous solution. PEG-b-PPA/DNA micelles exhibited uniform and reduced particle size ranging from 80 to 100 nm and lowered surface charge, compared with complexes of DNA with the corresponding cationic PPA carrier. PEG-b-PPA/DNA micelles maintained similar transfection efficiency as PPA/DNA complexes, which was comparable to that of PEI/DNA complexes in HepG2 cells, but yielded about 16-fold lower transgene expression in primary rat hepatocytes than PPA/DNA complexes. Following bile duct infusion in Wistar rats, PEG-b-PPA/DNA micelles mediated 4-fold higher and more uniform gene expression in the liver than PPA/DNA complexes. Liver function tests and histopathological examination indicated that PEG-b-PPA/DNA micelles showed low toxicity and good biocompatibility in the liver. This study demonstrated the potential of PEG-b-PPA/DNA micelles as an efficient carrier for liver-targeted gene delivery.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Synthetic scheme of PEG-b-PPA copolymer.
Figure 2
Figure 2
Gel electrophoresis mobility of DNA in PPA/DNA complexes and PEG-b-PPA/DNA micelles. Plasmid DNA (500 ng) and various amounts of PPAs or PEG-b-PPA were mixed at the indicated N/P ratio (primary amino groups in polymers to phosphate groups in DNA), followed by electrophoresis on an agarose gel (0.8% w/v) and stained with ethidium bromide.
Figure 3
Figure 3
Average particle size (a) and average zeta potential (b) of PEG-b-PPA/DNA micelles and PPA-DPA/DNA complexes.
Figure 4
Figure 4
TEM images of (a) PPA/DNA complexes (N/P = 10) and (b) PEG-b-PPA/DNA micelles (N/P = 10).
Figure 5
Figure 5
Transfection efficiency of PEI/DNA complexes (N/P = 10), PPA/DNA complexes and PEG-b-PPA/DNA micelles at various N/P ratios in (a) HepG2 cells and (b) primary rat hepatocytes 48 h after transfection. Each bar represents average ± standard division (n = 4). * denotes statistically significant comparison (p < 0.05) by the Student's t test.
Figure 6
Figure 6
Luciferase expression in rats on day 3 following intrabiliary infusion of PPA/DNA complexes (N/P = 10) and PEG-b-PPA/DNA micelles (N/P=10) at a DNA dose of 20 μg per rat. Each bar represents average ± standard division (n = 3).
Figure 7
Figure 7
Serum alanine transaminase (ALT) and aspartate transaminase (AST) levels in rats following intrabiliary infusion of PPA/DNA complexes (N/P = 10) and PEG-b-PPA/DNA micelles (N/P = 10) at a DNA dose of 20 μg per rat. Each bar represents average ± standard division (n = 3).
Figure 8
Figure 8
H&E stained tissue sections of the portal triad region of liver tissue harvested on day 3 from rats received (a) PPA/DNA complexes (N/P = 10) or (b) PEG-b-PPA/DNA micelles (N/P = 10).
See this image and copyright information in PMC

References

    1. Nguyen TH, Ferry N. Liver gene therapy: advances and hurdles. Gene Ther. 2004;11(Suppl 1):S76–S84. - PubMed
    1. Kren BT, Chowdhury NR, Chowdhury JR, Steer CJ. Gene therapy as an alternative to liver transplantation. Liver Transpl. 2002;8:1089–1108. - PubMed
    1. Prieto J, Herraiz M, Sangro B, Qian C, Mazzolini G, Melero I, Ruiz J. The promise of gene therapy in gastrointestinal and liver diseases. Gut. 2003;52:ii49–54. - PMC - PubMed
    1. Cristiano RJ, Smith LC, Kay MA, Brinkley BR, Woo SL. Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc. Natl. Acad. Sci. U. S. A. 1993;90:11548–11552. - PMC - PubMed
    1. Nathwani AC, Davidoff AM, Hanawa H, Hu Y, Hoffer FA, Nikanorov A, Slaughter C, Ng CY, Zhou J, Lozier JN, Mandrell TD, Vanin EF, Nienhuis AW. Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaque. Blood. 2002;100:1662–1669. - PubMed

Publication types

MeSH terms